RNAC
Price
$25.83
Change
-$0.60 (-2.27%)
Updated
May 20, 6:59 PM EST
80 days until earnings call
TSHA
Price
$3.09
Change
-$0.00 (-0.00%)
Updated
May 20, 6:59 PM EST
84 days until earnings call
Ad is loading...

RNAC vs TSHA

Header iconRNAC vs TSHA Comparison
Open Charts RNAC vs TSHABanner chart's image
Cartesian Therapeutics
Price$25.83
Change-$0.60 (-2.27%)
Volume$47.92K
CapitalizationN/A
Taysha Gene Therapies
Price$3.09
Change-$0.00 (-0.00%)
Volume$463.51K
CapitalizationN/A
View a ticker or compare two or three
RNAC vs TSHA Comparison Chart

Loading...

RNACDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TSHADaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
RNAC vs. TSHA commentary
May 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNAC is a Hold and TSHA is a Hold.

COMPARISON
Comparison
May 21, 2024
Stock price -- (RNAC: $26.43 vs. TSHA: $3.09)
Brand notoriety: RNAC and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RNAC: 30% vs. TSHA: 38%
Market capitalization -- RNAC: $470.35M vs. TSHA: $577.89M
RNAC [@Biotechnology] is valued at $470.35M. TSHA’s [@Biotechnology] market capitalization is $577.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RNAC’s FA Score shows that 1 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • RNAC’s FA Score: 1 green, 4 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, RNAC is a better buy in the long-term than TSHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RNAC’s TA Score shows that 4 TA indicator(s) are bullish while TSHA’s TA Score has 5 bullish TA indicator(s).

  • RNAC’s TA Score: 4 bullish, 4 bearish.
  • TSHA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both RNAC and TSHA are a good buy in the short-term.

Price Growth

RNAC (@Biotechnology) experienced а +24.85% price change this week, while TSHA (@Biotechnology) price change was +32.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.93%. For the same industry, the average monthly price growth was +5.91%, and the average quarterly price growth was +63.66%.

Reported Earning Dates

RNAC is expected to report earnings on Aug 08, 2024.

TSHA is expected to report earnings on Aug 12, 2024.

Industries' Descriptions

@Biotechnology (+1.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for RNAC with price predictions.
OPEN
A.I.dvisor published
a Summary for TSHA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
TSHA($578M) has a higher market cap than RNAC($470M). RNAC YTD gains are higher at: 3733.769 vs. TSHA (74.576).
RNACTSHARNAC / TSHA
Capitalization470M578M81%
EBITDAN/AN/A-
Gain YTD3733.76974.5765,007%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total Debt11MN/A-
FUNDAMENTALS RATINGS
RNAC: Fundamental Ratings
RNAC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
8
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
45
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RNACTSHA
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
87%
MACD
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
89%
View a ticker or compare two or three
Ad is loading...
RNACDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TSHADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HRIGX16.660.06
+0.36%
Harbor International Growth Admin
GCICX14.530.05
+0.35%
Goldman Sachs Intl Eq Insghts C
AFAZX11.310.03
+0.27%
Applied Finance Dividend Institutional
FABLX28.290.01
+0.04%
Fidelity Advisor Balanced A
TGRGX8.60-0.02
-0.23%
Transamerica International Focus I

RNAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAC has been closely correlated with AGEN. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if RNAC jumps, then AGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAC
1D Price
Change %
RNAC100%
+0.34%
AGEN - RNAC
93%
Closely correlated
+3.43%
SNPX - RNAC
92%
Closely correlated
-3.26%
ALLR - RNAC
86%
Closely correlated
-5.02%
NRXP - RNAC
86%
Closely correlated
+0.57%
TCON - RNAC
85%
Closely correlated
-6.54%
More

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with LOGC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then LOGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
-1.59%
LOGC - TSHA
45%
Loosely correlated
-0.90%
ORMP - TSHA
35%
Loosely correlated
-1.29%
CCCC - TSHA
33%
Poorly correlated
-4.86%
RNAC - TSHA
33%
Poorly correlated
+0.34%
ARRY - TSHA
33%
Poorly correlated
-3.35%
More